On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

NetworkNewsBreaks – Earth Science Tech, Inc. (ETST) Enters Strategic Partnerships to Market Hygee, Answer Global Epidemic

Company: Earth Science Tech, Inc. (ETST)
Category: News

Innovative biotechnology company Earth Science Tech (OTCQB: ETST) this morning announced its partnerships with Les Fous de la Com and Priori System communication agencies to promote its Hygee medical device for the self-screening of chlamydia. Per the update, ETST believes that Hygee is the answer to the global epidemic where, according to the Centers for Disease Control, the U.S. alone reported more than 2 million STD cases in 2016, the highest number on record (http://nnw.fm/1nPDm), with Chlamydia accounting for the majority of the cases. Under the agreement, Les Fous de La Com will focus on building a strong online presence for the Hygee product through an open communication channel and dedicated website, currently under construction. Priori System will work to endow visibility of the Hygee trademark in order to develop partnerships and associations at local, national and international levels. “Hygee is a concept that has the potential to revolutionize the way we screen for major sexually transmitted infections,” ETST CEO and Chief Science Officer Dr. Michel Aubé stated in the news release. “I urge anyone truly interested in this subject to read Chapter 10 of the book Major Infectious Diseases. 3rd edition by Chesson, Mayaud, and Aral. It is available on the web.”

To view the full press release, visit http://nnw.fm/k1pUz

About Earth Science Tech, Inc.

Earth Science Tech, Inc. offers the highest purity and quality high-grade full spectrum cannabinoid oil on the market. There are positive results in studies on breast cancer and immune cells through the University of Central Oklahoma; in addition to studies through DV Biologics that prove the company’s CBD oil formulation lowers cortisol and functions as a neuro-protectant, with positive result case studies through key health organizations. ETST formulates, markets and distributes the CBD oil used for its studies to the public, offering the most effective quality of CBD on the market. For more information, visit the company’s website at www.EarthScienceTech.com.

More from NetworkNewsBreaks

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217